Clinical Trial Update: Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula [Phase 2]

View source ↗

Summary

A Phase 2 trial of autologous cultured adipose-derived stem cells (ANTG-ASC) for complex perianal fistula was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perianal Fistula

Drugs mentioned

• ANTG-ASC (autologous adipose-derived stem cells)

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Complex Perianal Fistula | Phase 2 | Status: TERMINATED